David Meeker, MD, is stepping down from Cambridge, Mass.-based Sanofi Genzyme at the end of June 2017 as the company’s executive vice president and head, according to the Boston Globe. 1. Bill Sibold ...
Hosted on MSN
Rhythm Pharmaceuticals anticipates IMCIVREE launch in acquired hypothalamic obesity with $416M cash position
David Meeker, Chairman, President & CEO, highlighted "strong growth and continued momentum during the third quarter as we prepare to launch IMCIVREE in acquired hypothalamic obesity pending FDA ...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2025 Earnings Call Transcript November 4, 2025 Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results